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Transformation of atrioventricular canal endocardium into invasive mesenchyme is a critical antecedent of cardiac septation
and valvulogenesis. Previous studies by Potts et al. (Proc. Natl. Acad. Sci. USA 88, 1510±1520, 1991) showed that treatment
of atrioventricular canal endocardial and myocardial cocultures with TGFb3 antisense oligodeoxynucleotides blocked
mesenchyme formation. Based on this observation, we sought to: (i) identify the target tissue of TGFb3 antisense oligos
in this transformation bioassay, and (ii) more clearly de®ne the mechanism of TGFb3 function in atrioventricular canal
mesenchyme formation. In situ hybridization and immunohistochemistry showed little or no TGFb3 mRNA or protein
in the atrioventricular canal myocardium or endocardium prior to mesenchyme formation (stage 14; paraformaldehyde
®xation). However, by stage 18 transforming atrioventricular canal endocardial cells and mesenchyme as well as myocar-
dium were positive for both TGFb3 mRNA and protein. In culture bioassays, atrioventricular canal endocardial monolayers
pretreated with antisense phosphorothioate oligodeoxynucleotides to TGFb3 did not transform into invasive mesenchyme
in response to cardiocyte conditioned medium: the subsequent addition of exogenous TGFb3 protein relieved this inhibi-
tion. Control cultures without pretreatment or those receiving missense oligos generated similar numbers of invasive
mesenchyme in response to cardiocyte conditioned medium. Direct addition of TGFb3 protein to atrioventricular canal
endocardial monolayers in the absence of cardiocyte conditioned medium resulted in loss of cell:cell associations and
stimulated cellular hypertrophy, but did not engender invasive mesenchyme formation or alter endocardial proliferation
after 24 h of culture. Similar results were obtained with TGFb2 protein, either alone or in combination with TGFb3. The
results of this study indicate that: (i) atrioventricular canal endocardium expresses TGFb3 in response to a myocardially
derived signal other than TGFb3, (ii) atrioventricular canal endocardial TGFb3 functions in an autocrine fashion to elicit
selected characteristics necessary for cushion tissue formation, and (iii) TGFb3 alone or in combination with TGFb2 is
insuf®cient to transform atrioventricular canal endocardium into invasive mesenchyme in culture. q 1998 Academic Press
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INTRODUCTION myocardium) separated by an expanded acellular extracellu-
lar matrix (ECM),1 also referred to as cardiac jelly (Davis,
1924; Markwald et al., 1977, 1978). By stage 14 the chickThe ability to generate migrating mesenchymal cell popu-
lations from epithelial sheets in a reproducible temporal and
spatial pattern is a common mechanism used throughout 1 Abbreviations used: AV, atrioventricular; CCM, cardiocyte
embryogenesis. One of the earliest events in organogenesis conditioned medium; ECM, extracellular matrix; OT, out¯ow
is the formation of the primitive heart tube, which consists tract; PTO, phosphorothioate oligodeoxynucleotides; TGFb,
transforming growth factor b; PBS, phosphate-buffered saline.of two concentric epithelial layers (i.e., endocardium and
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embryonic heart is a right-side looped structure that is di- tion of AV endocardium, several questions remain regarding
its involvement on a mechanistic level. None of the datavided into presumptive sequential segments, i.e., primitive
atrium, atrioventricular canal (AV) region, primitive ventri- to date differentiate between three possible mechanisms of
action: (i) myocardially derived TGFb3 could function in ancle, and out¯ow tract (OT) (De la Cruz et al., 1989). At stage
16 a subpopulation of endocardial cells in the inferior AV autocrine fashion to elicit secretion of a paracrine transfor-
mation activity; (ii) myocardially derived TGFb3 could tra-region transforms from an epithelial to a mesenchymal mor-
phology and invades the subjacent extracellular matrix, fol- verse the ECM to signal certain characteristics of the trans-
formation process, with ultimate invasion regulated by a co-lowed by a similar transformation of the apposing superior
AV endocardium 10 h later (Moreno-Rodriguez et al., 1997). operative activity as yet unidenti®ed; or (iii) endocardial
expression of TGFb3 is an essential response of target cellsThis invasive mesenchyme becomes the AV endocardial
cushion tissue that constitutes the primordial valves of the for epithelial-to-mesenchymal transformation.
The focus of the present study was to assess the roleembryonic heart and is a critical component of valvular and
septal structures in the mature heart (Moller et al., 1994; of TGFb3 expression by AV endocardium relative to its
transformation into cushion mesenchyme. The resultantNakajima et al., 1996a,b; Wessels et al., 1996).
The regulation of epithelial-to-mesenchymal transfor- data are consistent with endocardially derived TGFb3 func-
tioning in an autocrine manner to manifest endocardial hy-mations is likely to involve both paracrine and autocrine
factors. By using a three-dimensional collagen gel culture pertrophy and a loss of cell:cell adhesion, which are charac-
teristic and necessary events in cushion mesenchyme for-model it has been shown that the epithelial±mesenchymal
transformation of AV endocardium is dependent upon co- mation. The role of myocardially expressed TGFb3 is yet
to be elucidated.culture with AV myocardium; ventricular myocardium
does not elicit mesenchyme formation (Runyan and Mark-
wald, 1983), suggesting a regionally restricted, paracrine-
acting factor produced by myocardium. Subsequent studies MATERIALS AND METHODS
showed that transformation-promoting activity was pres-
ent in conditioned medium from cardiocyte cultures. The In Situ Hybridization
generation of mesenchyme from AV endocardium by treat-
Digoxygenin-labeled single-strand RNA probes were prepared us-
ment with cardiocyte conditioned medium could be ing a DIG RNA labeling kit (Boehringer Mannheim, Indianapolis,
blocked by antibodies to EDTA-soluble cardiac ECM, dem- IN). A 462-bp fragment of chicken TGFb3 cDNA (base pairs 31±
onstrating the presence of a soluble inductive factor (Krug 492 in Accession No. M31154) was subcloned into pBluescript
et al., 1987; Markwald et al., 1990a,b; Mjaatvedt et al., (KS0). An antisense probe was produced using EcoRI and T3 RNA
polymerase; a sense probe was generated using HindIII and T7 RNA1991; Rezaee et al., 1993).
polymerase. Staged embryos (Hamburger and Hamilton, 1951) wereTransforming growth factor-b (TGFb) is a family of pro-
®xed with 4% paraformaldehyde in PBS and embedded in paraf®n.teins thought to regulate cellular proliferation and differenti-
Sections of 6±8 mm were cut and mounted onto slides coated withation at different stages of embryogenesis in vertebrates. The
3-triethoxysilylpropylamine (Merck, Darmstadt, Germany), depar-distribution patterns of several TGFbs and their receptors in
af®nized, hydrated, re®xed with 4% paraformaldehyde in 0.1 M PBdeveloping organs suggest that they may have signaling roles
(phosphate buffer) for 15 min, rinsed with 0.1 M PB, and digested
in epithelial±mesenchymal interactions (Sporn et al., 1986; with proteinase K (3 mg/mL) for 10 min at 377C, then acetylated
Ignotz and Massague, 1986; Yang and Moses, 1990; Mac- with 0.25% acetic anhydride in 0.1 M triethanolamine (pH 8.0) for
Lellan et al., 1993; Akhurst, 1994). During chicken endocar- 10 min. Sections were dehydrated next through a graded series
dial cushion tissue formation, TGFb is expressed by both of ethanol, air-dried, and hybridized (0.5 mg/mL of probe in 50%
deionized formamide containing 10 mM Tris±HCl, pH 7.6, 200 mg/endocardial cells and endocardially derived mesenchymal
mL yeast tRNA, 11 Denhardt's solution, 10% dextran sulfate, 600cells as well as myocardium (Choy et al., 1991; Runyan et
mM NaCl, and 0.25% SDS) at 507C for 14±16 h in a moist chamber.al., 1992; Nakajima et al., 1994; Ghosh and Brauer, 1996).
These sections were rinsed with 51 SSC followed by 50% for-Interestingly, the expression of TGFb1/b3 immunoreactivity
mamide, 21 SSC at 607C for 30 min each (twice), then 0.21 SSC forby AV and OT endothelial cells is upregulated in vivo just
20 min at 607C (twice). Hybridization was detected using alkaline-prior to mesenchyme formation and can be affected in cul-
phosphatase-conjugated anti-digoxygenin antibody (Boehringer
ture by cardiocyte conditioned medium (Nakajima et al., Mannheim; diluted 1:2000) and BCIP/NBT according to the manu-
1994). Potts et al. (1991) showed that TGFb3 expression was facturer's instructions.
critical to AV mesenchyme formation by treating cocultures
of AV endocardium and myocardium with antisense oligo-
Indirect Immuno¯uorescence Microscopydeoxynucleotides to TGFb3. Although no mesenchyme was
formed by these treated cultures, the experimental design The antibody used to localize TGFb3 was produced against
precluded a discrimination of the oligodeoxynucleotide tar- chicken recombinant protein (Cat. No. AB-244-NA, lot No. CK02;
get tissue, i.e., AV endocardium vs myocardium or both. R & D Systems, Minneapolis, MN). According to the manufacturer
Although these observations strongly suggest a critical func- this antibody neutralizes the bioactivity of TGFb3, but not that of
TGFb1, TGFb2, or TGFb5. Moreover, while it will react with alltion for TGFb3 during the epithelial±mesenchymal transi-
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FIG. 1. Expression of mRNA for TGFb3 during AV endocardial cushion tissue formation. (A) At stage 14, the heart consists of two
epithelial layers, the endocardium (e) and myocardium (m), separated by cardiac jelly. The mRNA for TGFb3 was detected in the out¯ow
tract (OT) myocardium; however, little or no signal was detected in OT endocardium and atrioventricular (AV) endocardium or myocardium
at this stage. (B) Stage 14 heart section processed with sense probe showed no detectable staining. (C) Stage 18 AV region showed positive
staining for TGFb3 mRNA in all three cell populations, i.e., the endocardial monolayer (e), cushion mesenchyme (me), and myocardium
(m). (D) High magni®cation view of boxed area in C shows transforming endocardial cells (arrowheads) and invasive mesenchyme (half
arrows) stained strongly for TGFb3 mRNA. (E) Stage 18 AV section processed with sense probe control. All panels represent sagittal
sections. AS, antisense probe; S, sense probe; ST, stage. Bar for (A±C and E), 100 mm; D, 20 mm.
three TGFb isoforms in ELISA and immunoblot analyses, it does studies of Ghosh and Brauer (1996) suggest that this antibody only
recognizes mature TGFb3.so with at least a 10-fold lower sensitivity than for TGFb3 (manu-
facturer's description; Ghosh and Brauer, 1996). Immunoblot analy- Cultures were drained of medium, rinsed with phosphate-buf-
fered saline (PBS), ®xed with 4% paraformaldehyde in PBS (pHsis showed that this antibody detected at least 1 ng of recombinant
chicken TGFb3 with or without reduction (data not shown). The 7.4) for 60 min at room temperature, and then rinsed with PBS.
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Specimens were blocked for 2 h with 5% nonfat dry milk in PBS endocardial monolayer, which will remain epithelial without the
addition of transformation-promoting preparations (Krug et al.,containing 0.1% Triton X-100, incubated with anti-TGFb3 anti-
body (10 mg of IgG/mL in blocking solution) at 47C overnight, rinsed 1987). At this time, monolayers were treated with either antisense
or missense PTO (0.5±1 mM in 0.3 mL CM199) or with CM199extensively with PBS, incubated with tetramethylrhodamine 5-(and
6)-isothiocyanate (TRITC)-conjugated rabbit anti-goat IgG (Cappel, alone. After an additional 12 h, all cultures were treated with CCM,
which can substitute for AV myocardium to elicit AV endocardialDurham, NC; diluted 1:100) for 2 h at room temperature, rinsed
with PBS again, transferred onto slides, coverslipped with mount- transformation into mesenchyme (Krug et al., 1987). Parallel cul-
tures of AV endocardium treated with the antisense PTO to TGFb3ing medium (0.2 M n-propylgallate in 90% glycerol/10% PBS), and
observed using an Olympus BX60 ¯uorescent microscope. received both CCM and chicken TGFb3 protein (R & D Systems;
5 ng/mL). After 48 h total incubation time, individual cultures wereNon®xed or paraformaldehyde-®xed stage 14±18 chicken em-
bryos were embedded in OCT (Miles, Elkhart, IN), and frozen in assessed for the presence of mesenchymal cells within the collagen
gel using Hoffman modulation optics. In this bioassay, ``inhibition2-methylbutane cooled by liquid nitrogen. Frozen sections were
mounted onto 3-triethoxysilylpropylamine-coated slides and air- of mesenchymal formation'' was de®ned as the situation when the
number of invasive mesenchymal cells was less than 2 standarddried. After rinsing with PBS for 15 min, sections were blocked
with 5% nonfat dry milk in PBS for 60 min, incubated with primary deviations below that exhibited by control explants cultured with
CCM alone.antibody in a moist chamber for 2 h at room temperature, rinsed
with PBS, incubated in TRITC-conjugated rabbit anti-goat IgG In the second type of AV endocardial transformation bioassay,
AV endocardial monolayers were established on collagen gels as(Cappel; diluted 1:100) for 1 h, and then rinsed with PBS and
mounted in mounting medium. above and then treated with CM199 containing: (i) chicken recom-
binant TGFb3 protein (R & D Systems; 0.5±50 ng/mL in 0.3 mL
CM199), (ii) human puri®ed TGFb2 protein (Nakarai, Tokyo, Ja-
pan), or (iii) both growth factors together. After 24 or 48 h totalAV Epithelial±Mesenchymal Transformation
incubation time, cultures were assessed microscopically for endo-Bioassay by Collagen Gel Culture
thelial proliferation and for characteristics of epithelial±mesenchy-
Two types of endothelial bioassay were carried out to evaluate mal transformation (i.e., cell hypertrophy, loss of cell-to-cell con-
the functional signi®cance of TGFb3 in the transformation of AV tacts, formation of migratory processes, and gel invasion).
endocardium into mesenchyme. These involved treatment of AV
endocardial monolayer cultures with either (i) cardiocyte condi-
tioned medium (CCM; Krug et al., 1987) following a pretreatment RESULTSwith antisense oligodeoxynucleotides to TGFb3 or (ii) basal culture
medium supplemented with chicken recombinant TGFb proteins.
TGFb3 Expression during AV Endocardial CushionPhosphorothioate oligodeoxynucleotides (PTO; Funakoshi, Tokyo,
Tissue FormationJapan) used in these experiments were identical to those used pre-
viously by Potts et al. (1991). The antisense PTO (5*-CGTACA-
In situ hybridization analysis of the stage 14 heart showedTCTTCATGTGC-3*) to chicken TGFb3 mRNA (Accession No.
little or no reactivity for TGFb3 transcripts in the myocar-M31154) spanned the initiation codon as determined by Jakowlew
dium and endocardium of the primitive atrium and AV re-et al. (1988). Control cultures included treatment with a missense
gion (Fig. 1A) relative to the sense probe control (Fig. 1B).PTO (5*-ATGGTGCACCTGACT-3*), which did not encode any
speci®c sequence in the GenBank database (Potts et al., 1991), or Interestingly, a strong signal was observed in the myocar-
CM199 alone. dium at the distal extreme of the OT region (i.e., trucus
AV endocardial monolayers were established as described pre- arteriosis/aortic sac). TGFb3 mRNA was also detected in
viously (Nakajima et al., 1994). Brie¯y, hearts from stage 140 the ventricle and proximal OT region, but the signal was
chicken embryos were collected in Earle's balanced salt solution less intense than that in the more distal OT (data not
(EBSS; Gibco BRL). AV regions were resected and cut longitudinally shown). Only a very low level of immunoreactivity for
to expose the lumen, then placed on top of drained collagen gels
TGFb3 protein was observed in the stage 14 heart (para-(0.3 mL/15 mm well) equilibrated in complete medium (CM199;
formaldehyde-®xed specimens) (Fig. 2A).Medium 199 containing 1% chick serum, 5 mg/mL insulin, 5 mg/
By stage 18, a subpopulation of endocardial cells in themL transferrin, 5 ng/mL selenium (ITS, Becton Dickinson), and
AV and OT regions has changed from an epithelial morphol-streptomycin/penicillin (Gibco BRL, Tokyo, Japan)). AV explants
were removed after 4 h of coculture leaving behind only an AV ogy to become mesenchymal cells that invade into the sub-
FIG. 2. Immunohistochemical staining for TGFb3 protein in stage 14 and 18 hearts with paraformaldehyde ®xation. The antibody used
for these studies has been reported to react with only the mature form of TGFb3 and does not recognize latent TGFb3 (Ghosh and Brauer,
1996). (A) At stage 14 no TGFb3 immunoreactivity was detected in the heart. By stage 18, endocardial, myocardial, and mesenchymal
cells all showed anti-TGFb3 antibody immunoreactivity in both the out¯ow tract (B) and atrioventricular canal (C). No detectable staining
in the cardiac jelly of either stage 14 or stage 18 hearts. The cardiac jelly in fresh-frozen tissue sections pretreated with 4 mM HCl or
plasmin was negative as well (data not shown). (D) Control section, secondary antibody alone. Left panels show light microscopic view
of the immuno¯uorescent images in right panels. AV, atrioventricular canal; OT, out¯ow tract; e, endocardium; m, myocardium; me,
cushion mesenchyme; cj, cardiac jelly. Bars in A, B, and D, 100 mm; C, 50 mm.
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jacent cardiac jelly, resulting in the formation of AV endo-
cardial cushion tissue. In addition, the ventricular muscle
layer has begun to form ventricular trabeculae, which re-
quires loss of its epithelial morphology as well (Manasek,
1970; Markwald et al., 1977, 1978). At this stage, TGFb3
mRNA transcripts were readily detectable throughout the
heart. In the AV region TGFb3 mRNA was present in myo-
cardium, endocardium, and its associated cushion mesen-
chyme (Fig. 1C), the latter of which stained somewhat
stronger than its overlying endocardium (Fig. 1D). The
stongest staining occurred in the ventricular myocardium.
The myocardium associated with the inferior and superior
AV cushions was moderately positive. By comparison, im-
munohistochemical staining for TGFb3 protein in the stage
18 chick heart was much more intense than that observed
at stage 14 and revealed a cytoplasmic deposition of TGFb3
in myocardium, endocardium, and mesenchymal cells of
both the AV and OT regions (Figs. 2B and 2C). No extracel-
lular staining was observed in the cardiac jelly of either
stage embryos subjected to paraformaldehyde ®xation: simi-
lar results were obtained with non®xed/frozen and Bouin-
®xed embryos as well (data not shown). Conditions for con-
verting latent TGFb3 to the mature form (e.g., heat or acid
pretreatment) were not tested on these specimens nor was
cryopreserved tissue, which might account for a lack of FIG. 3. Collagen gel culture model for evaluating PTO treatment
of AV endocardial monolayers. This diagram shows the temporalextracellular staining in the current study: Ghosh and
relationship of establishing AV endocardial monolayers from stageBrauer (1996) has used this same antibody from R & D
140 chick embryos and their subsequent treatment with either anti-Systems to demonstrate the presence of latent TGFb3 (and
sense or missense PTOs to TGFb3. Additional details are describedlack of the mature form) in the cardiac jelly of stage 14±16
under Materials and Methods. Abbreviations: m, myocardium; e,chick embryos.
endocardium; cj, cardiac jelly.
TGFb3 Antisense PTO Pretreatment of AV
Endocardial Monolayers in Culture Inhibits 4B). Pretreatment of AV endocardial monolayers with an
Mesenchyme Formation in Response to Cardiocyte antisense PTO to TGFb3 blocked mesenchyme formation
Conditioned Medium in response to CCM (Table 1, Fig. 4C). This inhibitory effect
of the TGFb3 antisense PTO on endocardial transformationPrior studies showed that immunoreactivity for TGFb1/
b3 in stage 14 chick OT/AV endocardial cells can be upregu- was reversed when the CCM was supplemented with re-
combinant chicken TGFb3 protein (Table 1 and Fig. 4D).lated by CCM (Nakajima et al., 1994). Whether this repre-
sented new synthesis by the target endocardial cells or the AV endocardial monolayers pretreated with missense PTO
(identical length and G/C content) formed mesenchyme inacquisition of TGFb protein from the CCM was not deter-
mined conclusively, although the data strongly suggested response to the addition of CCM similar to cultures without
PTO treatment (Table 1, Fig. 4E). Parallel experiments withthat a non-TGFb, EDTA-soluble protein(s) was responsible
for affecting endocardial expression of TGFb. In order to AV endocardium/myocardium cocultures receiving TGFb3
antisense vs missense PTO treatment duplicated the resultsresolve this question, AV endocardial monolayers from
stage 140 embryos (a ``pretransformed'' state, i.e., will not of Potts et al. (1991) (data not shown).
In order to determine if the antisense PTO treatment in-transform into mesenchyme without either AV myocardial
coculture or CCM treatment) were established on collagen hibited TGFb3 expression in target AV endocardial mono-
layers, immunohistochemistry was performed on these cul-gels and pretreated with antisense PTO identical to those
used by Potts et al. (1991). After a 12-h incubation with tures. As shown in Fig. 5, TGFb3 immunoreactivity was
observed in AV mesenchyme in cultures receiving CCMeither antisense or missense PTO, CCM was added as a
source of transformation-promoting activity (Fig. 3). As has alone or with missense PTO pretreatment (Figs. 5B and 5D),
while only a uniformly low level of reactivity was apparentbeen demonstrated previously (Krug et al., 1987), AV endo-
cardial monolayers seeded invasive mesenchyme into the in the monolayer of those with CM199 or TGFb3 antisense
PTO pretreatment prior to the addition of CCM (Figs. 5Aunderlying collagen gel in the presence of CCM, while con-
trols cultures remained epithelial (Table 1, Figs. 4A and and 5C). Given the paucity of material available in the trans-
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TABLE 1
Addition of TGFb3 Protein Relieves TGFb3 Antisense PTO Inhibition of AV Endocardial Transformation into Mesenchyme in Culture
Mesenchyme formed by 48 h
Culture conditions
Mesenchymal cells
Pretreatment Bioassay Frequencya per monolayerb
CM199 CM199 0/8 (0%) 0
CM199 CCM 8/10 (80%) 17 { 1
CM199 / TGFbPTO CCM 0/11 (0%) 2
CM199 / TGFb3 PTO CCM / TGFb3 4/5 (80%) 21 { 3
CM199 / missense PTO CCM 7/9 (78%) 20 { 2
Note. State 140 AV endocardial monolayers were prepared on a collagen gel lattice and pretreated for 12 h with CM199 alone or
containing 1 mM antisense or missense PTO as described under Materials and Methods. The resulting monolayers were then subjected
to various culture conditions including CM199, CCM, or CCM containing 5 ng/mL of chicken recombinant TGFb3.
a Number of monolayers forming mesenchyme after 48 h.
b Mean number of mesenchymal cells formed per monolayer {SE.
formation bioassay, it was not technically feasible to per- 6A): these invasive cells were usually found at the periphery
of the monolayer instead of underneath the monolayer asform Northern blot or RNase protection assays.
The observation that CCM required exogenous TGFb3 is more common with CCM treated cultures (cf. Figs. 7C
and 5B). By comparison, AV endocardial monolayers treatedprotein supplementation to override the inhibitory effect of
TGFb3 antisense PTO treatment of AV endocardium with CCM generated 4±7 times the number of invasive
mesenchymal cells (12 { 2 and 22 { 5 mesenchymal cellsstrongly suggests that active TGFb3 is absent in CCM.
However, it is possible that this CCM preparation contains per explant after 24 and 48 h in culture, respectively; Fig.
6A). Control monolayers treated with CM199 alone did notlatent TGFb as found the conditioned medium of OT endo-
cardial/myocardial cocultures and in vivo in the cardiac show any phenotypic characteristics of epithelial±mesen-
chymal transformation by 24 h in culture (Fig. 7A): after ajelly (Ghosh and Brauer, 1996). Immunoblot analysis of
CCM in the present study, either with or without acidi®ca- total of 48 h, some of these nontreated endocardial cells had
tion, failed to show any detectable reactivity at the level of apparently died or ¯oated off the gel surface (not shown).
sensitivity possible by this technique (lower limit of 1 ng/ Signi®cant cellular proliferation of the monolayer was an
mL). This observation is consistent with our earlier work additional effect of CCM treatment (about twofold after 24
which also was unable to demonstrate precipitable TGFb h and four-fold after 48 h; Fig. 6B); however, endocardial
from radiolabeled CCM with an antibody that recognizes cells treated with CM199 or TGFb3 alone did not show such
both TGFb1 and TGFb3 (Nakajima et al., 1994). a dramatic proliferative response (cell number increased by
about 50% after 24 h, with no further increase by the 48-h
time point). There was no signi®cant difference in the num-
Exogenous TGFb3 Initiates Cell:Cell Separation in ber of cells in individual monolayers at the time of either
Pretransformed AV Endocardial Monolayers in CCM or TGFb3 addition.
Culture It has been reported that TGFb2 is transcribed in the
developing chicken heart (Potts et al., 1992). Thus, oneIn order to further assess the role of endocardially derived
might propose a hypothesis that TGFb2 and TGFb3 actTGFb3 in the epithelial±mesenchymal transformation pro-
synergistically to affect complementary aspects of cushioncess, stage 140 AV endothelial monolayers cultures were
tissue formation. For this reason, we examined the biologi-evaluated for their morphological response to puri®ed
cal effect of TGFb2 alone and in combination with TGFb3TGFb3. As shown in Figs. 6A, 7A, and 7B, the addition of
on pretransformed AV endocardial cells in culture. In bothrecombinant chicken TGFb3 over a wide range of concen-
situations the results were similar to treatment withtrations (0.5±50 ng/mL) did not elicit invasive mesenchyme
TGFb3 alone (Figs. 6C and 6D). These experiments usedformation after 24 h in culture. However, TGFb3 addition
human TGFb2 because chicken TGFb2 protein was un-did result in signi®cant cell:cell separation and cellular hy-
available; however, the amino acid sequences of the twopertrophy of cells in the monolayer, as well as migratory
proteins are virtually identical. There is only one aminocells on the surface of the gel at the periphery of the mono-
acid difference between the mature form of the human andlayer (Fig. 7B). After an additional 24 h (48 h total treatment
chicken TGFb2 homologs (H40 in chicken corresponds totime), 3±5 endocardial cells per monolayer had invaded into
the collagen gel lattice in the TGFb3 treated cultures (Fig. N40 in human).
Copyright q 1998 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8807 / 6x36$$$283 02-02-98 10:37:54 dbas
106 Nakajima et al.
Copyright q 1998 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8807 / 6x36$$8807 02-02-98 10:37:54 dbas
107TGFb3 in Early Heart Development
in¯uences on AV endocardial transformation is regulated byDISCUSSION
a redundant mechanism (possibly TGFb3), (ii) myocardial
TGFb2 plays an autocrine role in formation of the ventricu-
TGFb3 Is Implicated in the Formation of AV lar septum, or (iii) failure to form a ventricular septum and
Endocardial Cushion Tissue the associate double outlet right ventricle is due indirectly
to a perturbation of out¯ow tract morphogenesis. In eitherPrevious experimental paradigms for examining the role
case it appears that in the mouse TGFb2 alone is not essen-of TGFb3 in AV cushion mesenchyme formation have not
tial to AV endocardial transformation. This may be due toallowed for a selective descrimination of endocardial vs
compensation by TGFb3 which could be tested by crossingmyocardial functions because both tissues express this pro-
TGFb2 and -b3 heterozygotes. It is important to note thattein. The present study has made use of the fact that AV
the distribution of TGFbs in chicken and mouse is differentendocardial monolayers treated with cardiocyte condi-
before extrapolating these data between species.tioned medium faithfully recapitulate both morphological
and molecular characteristics or AV mesenchyme forma-
tion (Krug et al., 1987; Mjaatvedt et al., 1991; Nakajima et AV Endocardial Expression of TGFb3 Regulates
al., 1994). Using this culture model the present study shows the Initial Aspects of Epithelial±Mesenchymal
that AV endocardial expression of TGFb3 is necessary for Transformation
its subsequent transformation into mesenchyme, consis-
tent with the observed upregulation of TGFb3 mRNA and The morphological characteristics of AV endocardial
transformation in vivo include cellular hypertrophy, lossprotein in this tissue. These data indicate that AV endocar-
dial TGFb3 plays an autocrine role in the loss of cell:cell of cell±cell contact, migratory appendage formation, and
invasion into the subjacent myocardial basement mem-adhesions and in facilitating cellular hypertrophy, without
which invasive mesenchyme will not form. In addition, it brane (Markwald et al., 1977, 1978). Exogenous addition of
either TGFb3 or -b2 protein to stage 140 AV endocardialwas shown that TGFb2 has similar biological effects as
TGFb3 on cultured AV endocardial monolayers, suggesting monolayers induced only cellular hypertrophy and cell:cell
separation after 24 h. These responses in culture are veryfunctional redundancy of these TGFbs in the developing
chick heart. No evidence was found to support a role for similar to those observed in vivo during the initial phase
of cushion tissue formation and temporally related to themyocardially derived TGFb as a paracrine inducer of AV
endocardial transformation. upregulation of TGFb3 in AV endocardium both in vivo
and in culture (Nakajima et al., 1994). The identity of theIn the mouse AV region three TGFbs are expressed differ-
entially, i.e., TGFb1 in endocardial/mesenchymal cells and factor that regulates this event is unknown, but a myocardi-
ally derived, non-TGFb protein has been suggested. ThisTGFb2 and TGFb3 in the myocardium (Heine et al., 1987;
Lehnert and Akhurst, 1988; Akhurst et al., 1990; Millan activity is likely to be contained in 30-nm particulates
found only in the cardiac jelly of mesenchyme-forming re-et al., 1991; Dickson et al., 1993). Gene knock-out mouse
experiments show that there is no obvious primary cardio- gions. Culture experiments show that these 30-nm particu-
lates can elicit mesenchyme formation from AV endocar-vascular abnormality during early development in either
TGFb1 or -b3 null embryos (Letterio et al., 1994; Dickson dial monolayers: antibodies to these particulates block this
event in cocultures with AV myocardium (Mjaatvedt andet al., 1995; Diebold et al., 1995; Kaartinen et al., 1995;
Proetzel et al., 1995), consistent with a hypothesis of func- Markwald, 1989; Mjaatvedt et al., 1991).
The observation that TGFb3 facilitates only a subset oftional redundancy between these TGFb isoforms. However,
severe ventricular septal defects (15 of 16 embryos), double events in AV cushion mesenchyme formation is consistent
with earlier data by Potts and Runyan (1989), who reportedoutlet right ventricle (3 of 16), and double inlet left ventricle
(4 or 16) were reported in the TGFb2 null mouse (Sanford et that ventricular myocardium supplied an accessory activity
to TGFb1- or -b2-treated AV endocardial monolayers to com-al., 1997). Both mitral and tricuspid valves were apparently
normal, but the out¯ow septum failed to muscularize. plete its transformation into invasive mesenchyme. These
experiments suggest that this complementary activity wouldThese observations suggest that: (i) any putative myocardial
FIG. 4. AV endocardial monolayers pretreated with TGFb3 antisense PTO do not transform into invasive mesenchyme in the presence of
cardiocyte conditioned medium. AV endocardial monolayers from stage 140 embryos were cultured for 12 h in the presence or absence of
TGFb3 antisense PTO and then evaluated 36 h later by optical sectioning for responsiveness to transformation promoting activity present
in CCM. (A) Monolayers cultured in CM199 did not show endothelial±mesenchymal transformation. (B) Monolayers pretreated with CM199
transformed into invasive mesenchyme in response to CCM. (C) Monolayers pretreated with TGFb3 antisense PTO (AS) did not transform
into mesenchyme in response to CCM. (D) When AV endocardial monolayers pretreated with TGFb3 antisense PTO received CCM supple-
mented with exogenous TGFb3 (5 mg/mL) mesenchymal invasion of the collagen gel lattice was observed. (E) Pretreatment of AV endocardial
monolayers with a missense PTO did not prevent mesenchyme formation in response to CCM. Bar, 100 mm.
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FIG. 5. Treatment of AV endocardial monolayers with antisense PTO to TGFb3 inhibits expression of TGFb3 immunoreactivity. AV
endocardial monolayers from stage 140 embryos were treated under the various culture conditions shown in Table 1 and Fig. 3 and
evaluated for the expression of TGFb3 protein by immunohistochemistry. Neither mesenchyme formation nor TGFb3 immunoreactivity
occurred in monolayers receiving CM199 alone (A) or pretreated with antisense PTO to TGFb3 prior to CCM addition (C). In contrast,
both mesenchyme formation and TGFb3 immunoreactivity was observed in cultures receiving CCM alone (B) or in conjunction with
missense PTO pretreatment (D). In the latter two situations, TGFb3 immunoreactivity was strongest in invasive mesenchymal cells,
with the next most intense signal coming from surface cells in the initial phases of transformation. Bar, 50 mm.
be expressed by all regions of the early myocardium, i.e., Several other differentiative events have been observed
during endocardial cushion mesenchyme formation, suchthose both with and without mesenchyme formation. This
as yet unidenti®ed accessory factor would complement the as upregulation of urokinase (McGuire and Orkin, 1992),
collagenase (Nakagawa et al., 1992), ®bronectin (Icardo andaction of another protein(s) responsible for upregulation of
endocardial TGFb3 expression. Both transferrin (Isokawa et Manasek, 1983; Kitten et al., 1987), and type I procollagen
(Sinning et al., 1988), and downregulation of NCAM expres-al., 1994) and basic ®broblast growth factor (Parlow et al.,
1991) have been identi®ed in the early myocardium; how- sion (Mjaatvedt and Markwald, 1989). At present it is un-
clear which, if any, of these are direct targets of AV endocar-ever, preliminary evaluations of a synergistic function with
exogenous TGFb3 have proven inconclusive. dial TGFb3 expression. The loss of cell:cell adhesion ob-
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FIG. 6. Quantitative evaluation of invasive mesenchyme formation and proliferation from AV endocardial monolayers cultured with
CCM vs TGFb. AV endocardial monolayers were prepared on collagen gel lattice from stage 140 embryos and incubated in CM199 with
or without TGFb supplementation (TGFb2 vs TGFb3, alone or in combination). (A, B) Monolayers treated with TGFb3 alone over a 100-
fold range of concentration were similar to control cultures in CM199 alone: by 48 h no more than 3±5 mesenchymal cells had formed
per monolayer with only a slight increase in cell number. In contrast, cultures endothelial cells treated with CCM alone generated an
average of 23 mesenchymal cells per monolayer and had more than four times the number of endothelial cells. (C, D) Monolayers treated
with TGFb2 protein alone or in combination with TGFb3 were similar to those receiving only TGFb3. There was no signi®cant difference
in the initial number of endothelial cells in any of the target AV monolayers (Mann±Whitney U test). Number of explants tested: (A, B)
17 for CM199, 7 for each TGFb3 concentration, and CCM; (C, D) 8 and 9 for TGFb2 (5 and 50 ng/ml, respectively); 10 and 9 for TGFb2
/ b3 (5 and 50 ng/ml, respectively). Values represent average numbers of cells {SEM.
served in the present study would be consistent with a population of endocardial cells prestimulated in ovo. The
former postulate seems unlikely as there is no apparentreciprocal relationship between TGFb3 and N-CAM expres-
sion. The antibody perturbation experiments for the TGFb difference in the amount of mesenchyme between cocul-
tures of AV myocardium and endocardium in the presencetype II receptor by Brown et al. (1996) showed that invasion
could be blocked in early AV endocardium/myocardium co- or absence of exogenous TGFb (Potts and Runyan, 1989).
Relative to the later possibility, unpublished studies bycultures. However, a lack of procollagen expression by inva-
sive mesenchyme from older explants suggests that both Ramsdell and Markwald have shown that AV mesenchyme
conditioned medium is one of the few sources that cantransformation and differentiation may be dependent upon
TGFb expression in AV endocardium and mesenchyme. substitute for AV myocardium or CCM (notochord and limb
ectoderm being the only other known sources, Krug et al.,When target AV endocardial cells were cultured with
TGFb3 alone for 48 h, a small number of mesenchymal 1995). Interestingly, the developmental stage of the embryo
used to establish the AV endocardial monolayers and thecells invaded the collagen gel (though much fewer than with
CCM treatment). This could be the result of two different duration of coculture with myocardium are directly linked
to the percentage of endocardial cells competent to trans-scenarios; i.e., TGFb3 is inhibitory to invasion or a missing
hypothetical migratory factor is produced locally by a sub- form into mesenchyme in response to these signals. For
Copyright q 1998 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8807 / 6x36$$$284 02-02-98 10:37:54 dbas
110 Nakajima et al.
FIG. 7. Morphological analysis of AV endocardial monolayers treated with TGFb3 protein. (A) AV endocardial monolayers from stage
140 embryos cultured with CM199 alone remained epithelial and showed no mesenchymal phenotypic characteristics. (B) In contrast,
although invasive mesenchyme was not formed, AV monolayers treated with TGFb3 alone (5 ng/mL) showed cellular hypertrophy, cell:cell
separation, and formation of migratory appendages by 24 h in culture. (C) After 48 h in culture a few cells (arrows) were observed within
the collagen gel lattice. Mesenchymal cells formed by TGFb3 treatment generally occurred at the periphery of the monolayers in contrast
to CCM treated and myocardial coculture experiments that generate mesechyme primarily underneath the monolayer.
example, stage 140 embryos (18±20 somites) do not produce cells secrete TGFb as a high-molecular-mass, latent com-
plex which contains mature TGFb associated with its la-mesenchyme in the standard bioassay (removing the myo-
cardium after 4 h of coculture), whereas parallel cultures tency-associated protein and latent TGFb-binding protein
(LTBP; Miyazono et al., 1988; Kanzaki et al., 1990; Tsuji etthat start with embryos only 4 h older generate invasive
mesenchyme without supplementation, de®ning a critical al., 1990). The large latent TGFb complex is associated with
the extracellular matrix via the latent TGFb-binding pro-point of in ovo maturation (Krug, unpublished observa-
tions). For this reason, embryos beyond stage 140 should tein (Flaumenhaft et al., 1993; Saharinen et al., 1996). This
is a component of extracellular micro®brils and concen-not be used to evaluate candidate transforming agents of
myocardial origin. trates the TGFb around cells (Taipale et al., 1996; Nakajima
et al., 1997). During endocardial cushion tissue formation
in the mouse embryo (pc day 9.5) the large latent TGFb
Potential for Posttranslational Regulation of complex is distributed surrounding a subpopulation of AV
TGFb3 Activity endocardial and all cushion mesenchymal cells, but is ab-
sent in the acellular cardiac jelly (Nakajima et al., 1997).Active TGFbs are highly hydrophobic, basic proteins that
are rapidly lost from solution by binding to many proteins Antibodies to LTBP-1 blocked both invasive mesenchyme
formation and endocardial proliferation in cocultures ofwith a relatively high af®nity (Brown et al., 1990). Most
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Davis, C. L. (1924). The cardiac jelly of the chick embryo. Anat.mouse AV myocardium and endocardium: lower concentra-
Rec. 27, 201.tions of anti-LTBP-1 selectively inhibited cell invasion,
De La Cruz, M. V., Sanchez-Gomez, C., and Palomino, M. A. (1989).which is relieved by the addition of TGFb1 protein. This
The primitive cardiac regions in the straight tube heart (stage 90)may be mirrored in the chicken given the presence of latent
and their anatomical expression in the mature heart: An experi-TGFb in the premesenchyme cardiac jelly (Ghosh and
mental study in the chick embryo. J. Anat. 165, 121±131.
Brauer, 1996). Activation of this pool of latent TGFb may Dickson, M. C., Slager, H. G., Duf®e, E., Mummery, C. L., and Ak-
require proteases secreted by the AV endocardium and cush- hurst, R. J. (1993). RNA and protein localization of TGF beta 2
ion mesenchyme (McGuire and Orkin, 1992). in the early mouse embryo suggest an involvement in cardiac
In summary, we have shown that AV endocardial mono- development. Development 117, 625±639.
layers pretreated with an antisense PTO speci®c for TGFb3 Dickson, M. C., Martin, J. S., Cousins, F. M., Kulkarni, A. B., Karls-
son, S., and Akhurst, R. M. (1995). Defective haematopoiesis andfailed to carry out the complete epithelial±mesenchymal
vasculogenesis in transforming growth factor b1 knock out mice.transformation in response to CCM. The conclusions of this
Development 121, 1845±1854.study are: (i) that endothelially synthesized TGFb3 plays
Diebold, R. J., Eis, M. J., Yin, M., Ormsby, I., Boivin, G. P., Darrow,an essential autocrine function for cushion mesenchyme
B. J., Saf®tz, J. E., and Doetschman, T. (1995). Early-onsetformation in culture; (ii) there may be functional redun-
multifocal in¯ammation in the transforming growth factor b1-dancy between TGFb3 and -b2 in vivo; and (iii) it appears
null mouse is lymphocytic mediated. Proc. Natl. Acad. Sci. USA
unlikely that the myocardially derived stimulus for AV en- 92, 12215±12219.
docardial transformation is a TGFb-like protein. Resolution Flaumenhaft, R., Abe, M., Sato, Y., Miyazono, K., Harpel, J., Heldin,
of this ®nal point awaits using a similar antisense PTO CH., and Rifkin, D. B. (1993). Role of the latent TGF-b binding
strategy with cardiocyte cultures to determine if this leads protein in the activation of latent TGF-b by co-cultures of endo-
thelial and smooth muscle cells. J. Cell Biol. 120, 885±1002.to a loss of transformation-promoting activity in the condi-
Ghosh, S., and Brauer, P. R. (1996). Latent transforming growthtioned medium and, if so, does this result from a selective
factor-b is present in the extracellular matrix of embryonic heartsinhibit of TGFb3 secretion by myocardial cells. If not, myo-
in situ. Dev. Dyn. 205, 126±134.cardially derived TGFb3 may have an autocrine function
Hamburger, V., and Hamilton, H. L. (1951). A series of normalto affect secretion of other proteins that elicit endocardial
stages in the developing chick embryo. J. Morphol. 88, 49±92.transformation and/or proliferation.
Heine, U. I., Munoz, E. F., Flanders, K. C., Ellingsworth, L. R., Peter
Lam, H. Y., Thompson, N. L., Roberts, A. B., and Sporn, M. B.
(1987). Role of transforming growth factor-b in the development
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